This discovery represents a major innovation
Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body.
This discovery represents a major innovation, said Adah Almutairi, PhD, associate professor and director of the joint UC San Diego-KACST Center of Excellence in Nanomedicine. Up to now, she said, only a handful of strategies using light-triggered release from nanoparticles have been reported.
The mechanism, described in the April 1, 2014 online issue of ACS Nano, employs near-infrared (NIR) light from a low-power laser to heat pockets of water trapped within non-photo-responsive polymeric nanoparticles infused with drugs. The water pockets absorb the light energy as heat, which softens the encapsulating polymer and allows the drug to be released into the surrounding tissue. The process can be repeated multiple times, with precise control of the amount and dispersal of the drug.
“A key advantage of this mechanism is that it should be compatible with almost any polymer, even those that are commercially available,” said Mathieu Viger, a post-doctoral fellow in Almutairi’s laboratory and co-lead author of the study. “We’ve observed trapping of water within particles composed of all the biodegradable polymers we’ve so far tested.”
The method, noted Viger, could thus be easily adopted by many biological laboratories.
The combined use of hydrated polymers and near-infrared light appears to resolve a host of technological and health barriers that have hindered previous, similar approaches. Earlier efforts to use NIR-triggered release have not been widely exploited because they required special designer polymers, expensive high-powered lasers and/or the co-encapsulation of inorganic particles whose safety in the body remains questionable.
The new method described by Almutairi and colleagues in the departments of Mechanical and Aerospace Engineering, Neuroscience, and Chemistry and Biochemistry at UC San Diego uses NIR at a vibrational wavelength cued to excite water molecules, which absorb the optical energy and convert it to heat. NIR is capable of penetrating biological tissues to greater depths than visible or ultraviolet light.
Co-lead author Wangzhong Sheng, a graduate student in Department of Mechanical and Aerospace Engineering, explained the selectivity of heating by comparing the trapped water within particles to a glass of water and the surrounding water within the solution or tissue to a bathtub. The smaller amount of water is heated much more rapidly because of the enormous volume difference.
An obvious use of the method, said Almutairi, is light-triggered drug delivery, but with more research, she anticipates the new method could provide a variety of industrial, medical and scientific applications, including “any technological application requiring that chemistry be controlled in time and in space, such as in catalysis or self-repairing materials or light-activated sunscreens or pesticide dosing.”
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Advanced Drug Delivery Systems Market to Witness Huge Growth by 2025 |3M, Allergan PLC, Therajecton March 24, 2020 at 8:28 am
Advanced Drug Delivery Systems Market Research Study - The exploration report comprised with market data derived from primary as well as secondary research techniques. The points covered in this study ...
- Global COPD Drug Delivery Devices Market (2019 to 2027) - Featuring AstraZeneca, Boehringer Ingelheim & Novartis Among Otherson March 24, 2020 at 3:08 am
Dublin, March 24, 2020 (GLOBE NEWSWIRE) -- The "COPD Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and ...
- Liposome Drug Delivery Market is Forecasted to Reach US$ 8 Billion By 2026 – QY Researchon March 24, 2020 at 2:12 am
In the last several years, the development of the Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of the Liposomes Drug Delivery market is ...
- Injectable Drug Delivery Devices Market Global Potential Growth,Share,Demand And Analysis Of Key Players Forecasts To 2023on March 24, 2020 at 1:10 am
WiseGuyReports.Com Publish a New Market Research Report On -"Injectable Drug Delivery Devices Market Global Potential Growth,Share,Demand And Analysis Of Key Players Forecasts To 2023". Injectable ...
- Technique improves characterization of drug delivery systemson March 23, 2020 at 4:54 am
Postnova Analytics reports that its CF2000 Centrifugal Field Flow Fractionation system is delivering exciting new data to scientists developing drug delivery systems. One of the grand challenges of ...
- Wearable Injectors Market 2020-2024 | Demand for Self-administrative Drug Delivery Devices to Boost Growth | Technavioon March 20, 2020 at 1:00 pm
Demand for self-administrative drug delivery devices has been instrumental in driving the growth of the market. Wearable Injectors Market 2020-2024: Segmentation Wearable Injectors Market is segmented ...
- Lexaria Bio begins COVID-19 drug delivery programon March 19, 2020 at 4:20 am
is commencing a program, in collaboration with leading laboratories in Canada and USA, to study the benefits of its DehydraTECH drug delivery platform for enhancing de ...
- Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Programon March 19, 2020 at 3:24 am
KELOWNA, BC / ACCESSWIRE / March 19, 2020 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, announces it is commencing a program, ...
- Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.on March 19, 2020 at 12:35 am
/PRNewswire/ -- The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during ...
- Injectable Drug Delivery Market To Reach USD 1,208.49 Billion By 2027on March 18, 2020 at 6:52 am
The Injectable Drug Delivery Market is estimated to reach USD 1,208.49 Billion by 2027, according to a new report by Reports and Data. This can be mainly associated with the growing incidences of ...
via Bing News